Eisai, Alzheimer’s Association accepting 2010 C.A.R.E. Pharmacy Award nominations
WOODCLIFF LAKE, N.J. Drug maker Eisai and the Alzheimer’s Association are calling for nominations for the 2010 C.A.R.E. Pharmacy Award, Eisai announced.
The award, now in its 10th year, is meant to recognize pharmacists who help patients with Alzheimer’s disease and their caregivers, and Eisai said it reflected the company’s “human health care” mission, which emphasizes the role in health care of patients and their families.
“Alzheimer’s is a disease that affects both patients and their caregivers, and Eisai’s commitment to the patient and caregiver communities is unwavering,” Eisai president and COO Lonnel Coats said. “As part of that commitment, we are proud to be working with the Alzheimer’s Association to honor the extraordinary contributions of pharmacists who are making a difference in the lives of people affected by Alzheimer’s disease.”
For eligibility, nominees must be licensed pharmacists involved in activities over the past year that have helped patients with Alzheimer’s disease, and the activities must have “had a positive effect on patients and/or their families.” Nominations can be submitted until July 31 at carepharmacyaward.com. In addition to recognition for the winning pharmacist, the pharmacist’s local Alzheimer’s Association chapter will receive a $2,500 donation, while another $2,500 donation will go to the Alzheimer’s Association chapter in the region from which the most nominations are submitted.
Walgreens puts hold on its plan to sell genetic test kits in stores
DEERFIELD, Ill. Apparently having second thoughts on a deal that would have put genetic testing kits up for sale in its stores, Walgreens said Thursday it would delay any move to offer the products until questions posed by the Food and Drug Administration about the product are resolved.
Those questions arose following published reports that Pathway Genomics would begin selling its genetic test kits in most Walgreens stores this week. The reports triggered new scrutiny from the FDA, which indicated this week that it has no record of having approved the kits for sale.
The federal agency – which may be adopting a more assertive stance to product reviews and approvals under commissioner Margaret Hamburg – told Reuters news service that it would “take a hard look at any claims made by the company.”
Both Walgreens and Pathway asserted earlier this week that FDA approval is not needed for the sale of test kits in a retail setting. But FDA spokesperson Erica Jefferson told Reuters on Tuesday, “If a company is making claims about a product that hasn’t been reviewed or validated by FDA, we want to make sure the information to consumers is accurate and the test will do what it says it will do.”
In response, Walgreens reversed course. The company said Thursday has shelved, for now, its plan to go ahead with a rapid rollout of the kits.
“In light of the FDA contacting Pathway Genomics about its genetic test kit and anticipated ongoing discussions between the two parties, we’ve elected not to move forward with offering the Pathway product to our customers until we have further clarity on this matter,” said Walgreens spokesman Jim Cohn.
The tests are saliva-based, and are intended to assess via DNA analysis patients’ genetic markers for such potential conditions as diabetes and cancer.
Mayo Clinic Health Manager seeks to organize personal medical information
REDMOND, Wash. Managing a health condition can be difficult enough, but organizing personal medical information can be even more time-consuming, according to a study commissioned by the Mayo Clinic and Microsoft, which operates the online resource HealthVault. The two have developed the Mayo Clinic Health Manager, a HealthVault application that helps people organize health information.
The study was the result of a survey of 1,065 adults conducted by Opinion Research Corp. in April. Nearly one-third of respondents said they spent more time keeping information organized than finding answers to health questions or dealing with chronic conditions.
At the same time, almost half said they regularly left doctor’s offices without asking an important medical question or giving the physician crucial information affecting their health, while 9-in-10 had reported doing so in the past.